Skip to content

US · ZEPP · CONSUMER ELECTRONICS

Zepp Health Corporation (ZEPP) intrinsic value and stock valuation

$2.31as of 2026-11-21 · Mkt cap 65.45M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Zepp Health Corporation DCF and intrinsic value

InvestorsCraft values ZEPP with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from ZEPP’s statements →

Zepp Health Corporation Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Technology · Consumer Electronics Gorinchem, GR 4207 HG zepp.com

How the business is doing

Fiscal 2015–2025, USD

Revenue
$1.82B+14.3% 5y CAGRd
20152025
Net income
-$-280.92M
20152025
Free cash flow
-$-185.14M
20152025
Total equity
$1.5B+29.2% 5y CAGRd
20152025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2015–2025, USD
20252024202320222021
Revenue$1.82B$1.33B$352.6M$615.7M$968.7M
Operating income-$-204.93M-$-345.04M-$-30.43M-$-60.97M$14.6M
Net income-$-280.92M-$-554.13M-$-31.13M-$-42.85M$21.4M
EPSd-$-283.76M-$-34.25M-$-2.05M-$-2.78M$1.29M
Operating cash flow-$-179.65M-$-24.39M$6.02M-$-17.11M-$-52.1M
Capital expenditure-$-5.48M-$-1.49M-$-240K-$-220K-$-7.14M
Free cash flow-$-185.14M-$-25.88M$5.78M-$-17.32M-$-59.23M
Total assets$3.95B$3.86B$635.7M$758.3M$954.5M
Total debt$1.59B$1.33B$195.8M$248.6M$211.6M
Net debt$804.8M$521.2M$55.3M$108.5M-$-25.17M
Total equity$1.5B$1.84B$352.8M$386.5M$460.1M
Cash and short-term investments$789.7M$815.5M$145.7M$145.1M$240.6M
Income statement
20252024202320222021
Revenue$1.82B$1.33B$352.6M$615.7M$968.7M
Cost of revenue$1.1B$820.6M$260.3M$496.4M$766.4M
Gross profit$711.6M$512.9M$92.3M$119.4M$202.4M
Research and development expenses$317.7M$337.1M$51.5M$76.9M$79.8M
Selling, general and administrative expenses$582.6M$520.9M$71.3M$103.5M$696.6M
Other expenses$16.2M$0.00$0.00$0.00-$-588.65M
Operating expenses$916.6M$857.9M$122.7M$180.3M$187.8M
Cost and expenses$2.02B$1.68B$383.1M$676.7M$954.2M
Interest income$10.7M$26.8M$3.09M$1.83M$2.59M
Interest expense$39.9M$40.5M$6.75M$8.47M$6.96M
Depreciation and amortization$31.7M$36.6M$7.69M$8.71M$8.04M
Ebitda-$-191.48M-$-345.66M-$-20.17M-$-38.18M$31.5M
Operating income-$-204.93M-$-345.04M-$-30.43M-$-60.97M$14.6M
Total other income/expenses, net-$-58.2M-$-108.55M-$-3.06M$8.23M$8.33M
Income before tax-$-263.13M-$-453.59M-$-33.49M-$-52.74M$22.9M
Income tax expense$17.8M$100M-$-2.43M-$-9.79M$1.67M
Net income-$-280.92M-$-554.13M-$-31.13M-$-42.85M$21.4M
Weighted average shares outstanding$990K$16.2M$15.2M$15.4M$15.8M
Weighted average diluted shares outstanding$990K$16.2M$15.2M$15.4M$16.5M
Balance sheet
20252024202320222021
Cash and short-term investments$789.7M$815.5M$145.7M$145.1M$240.6M
Net receivables$514.5M$577.7M$82M$125.3M$170.6M
Inventory$508.8M$414.5M$84.9M$147.4M$197.2M
Total current assets$2.05B$1.84B$316.8M$425.9M$616.5M
Property, plant and equipment, net$53.3M$75.6M$15.8M$23.9M$38M
Goodwill and intangible assets$162.2M$121.7M$19.5M$27.3M$30.8M
Long-term investments$1.55B$1.66B$241.5M$243.7M$243.5M
Total non-current assets$1.9B$2.02B$318.9M$332.4M$337.9M
Total assets$3.95B$3.86B$635.7M$758.3M$954.5M
Accounts payable$564.8M$372.8M$37.3M$65.7M$206.6M
Short-term debt$1.17B$765.6M$72.6M$145.5M$86.4M
Deferred revenue$530K$37.5M$7.84M$9.11M$14.5M
Total current liabilities$2.01B$1.43B$155.2M$240.2M$337.5M
Long-term debt$423.6M$563.8M$123.2M$103.1M$125.2M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$443.8M$587.5M$127.7M$131.6M$156.8M
Capital lease obligations$7.71M$14.7M$3.2M$4.56M$11.2M
Total liabilities$2.45B$2.01B$282.8M$371.8M$494.4M
Common stock$180K$190K$30K$20K$20K
Retained earnings-$-80.07M$208.9M$104.4M$135.7M$199.4M
Accumulated other comprehensive income (loss)-$-278.87M-$-293.25M-$-14.01M$15.2M$4.59M
Total equity$1.5B$1.84B$352.8M$386.5M$460.1M
Total investments$1.55B$1.67B$246.7M$248.7M$247.3M
Total debt$1.59B$1.33B$195.8M$248.6M$211.6M
Net debt$804.8M$521.2M$55.3M$108.5M-$-25.17M
Cash flow statement
20252024202320222021
Net income-$-280.18M-$-75.81M-$-4.39M-$-6.33M$21.4M
Depreciation and amortization$31.7M$5.02M$1.09M$1.27M$8.04M
Stock-based compensation$17.4M$4.78M$1.24M$1.06M$0.00
Change in working capital-$-109.97M$7.66M$6.76M-$-12.02M-$-97.44M
Accounts receivable-$-80.68M$400K$6.18M$460K$47.2M
Inventory-$-154.48M$5.55M$7.33M$4.08M-$-12.88M
Accounts payable$197.9M$14.8M-$-3.93M-$-19.77M-$-104.35M
Net cash provided by operating activities-$-179.65M-$-24.39M$6.02M-$-17.11M-$-52.1M
Investments in property, plant and equipment-$-3.61M-$-1.4M-$-230K-$-180K-$-8.23M
Acquisitions, net$0.00$0.00$60K$10K$5.65M
Net cash used for investing activities$10.4M-$-1.58M$1.09M-$-910K-$-165.75M
Common stock issued$0.00$0.00$0.00$0.00$850K
Common stock repurchased-$-8.66M-$-2.28M-$-360K-$-1.19M-$-2.13M
Dividends paid$0.00$0.00$0.00-$-920K$0.00
Net cash used for financing activities$173.7M$480K-$-5.88M$6.19M$101.5M
Net change in cash$15.4M-$-29.73M-$-90K-$-13.99M-$-111.09M
Cash at end of period$789.7M$110.7M$19.8M$20.6M$236.8M
Operating cash flow-$-179.65M-$-24.39M$6.02M-$-17.11M-$-52.1M
Capital expenditure-$-5.48M-$-1.49M-$-240K-$-220K-$-7.14M
Free cash flow-$-185.14M-$-25.88M$5.78M-$-17.32M-$-59.23M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Zepp Health Corporation

        Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.

        CEO
        Wang Huang
        Employees
        763
        Beta
        1.84

        Explore

        Frequently asked questions

        What is the intrinsic value of Zepp Health Corporation (ZEPP)?

        InvestorsCraft does not currently publish an intrinsic value for ZEPP. How the IC value is calculated.

        Is ZEPP undervalued?

        InvestorsCraft does not publish an undervaluation signal for ZEPP at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.